Athena Licenses Genetic Test for Intellectual Disability | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Athena Diagnostics, a subsidiary of Thermo Fisher Scientific, has licensed from Toronto's Centre for Addiction and Mental Health the rights to develop a test for intellectual disability based on CC2D2A gene mutations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.